At Different Mental Health, we know that bipolar disorder doesn’t just affect mood—it touches every area of life, especially for women balancing their mental health with physical wellness, reproductive goals, and body image. If you’ve been diagnosed with bipolar disorder or suspect you’re struggling with it, you’re not alone—and you deserve a treatment plan that supports both your mental and physical health.
Understanding Bipolar Disorder in Women
For women, the journey with bipolar disorder often comes with challenges that extend beyond mood swings or energy shifts. Hormonal fluctuations, menstrual cycles, pregnancy planning, and side effects like hair thinning or weight gain can all complicate treatment decisions. While achieving mood stability is a priority, the path to get there should be one that respects your whole self—your goals, identity, and future.
How Hormones Influence Bipolar Symptoms in Women
Many of the most widely used medications for bipolar disorder—such as valproate (Depakote), lamotrigine (Lamictal), carbamazepine (Tegretol), and second-generation antipsychotics—are highly effective. However, they can also come with side effects that disproportionately affect women, both physically and emotionally.
Hair loss and skin changes are common complaints with medications like valproate and carbamazepine. While not medically dangerous, they can have a real impact on confidence and well-being.
Weight gain and metabolic disruption are also concerns, particularly with certain antipsychotics and mood stabilizers. These changes may not only affect body image, but also increase the risk of insulin resistance, diabetes, and reproductive complications like polycystic ovary syndrome (PCOS). Research has linked valproate specifically to a significantly increased risk of PCOS, a condition that can cause irregular periods, acne, hair growth, and difficulty conceiving (Ismayilova & Şahin, 2023).
Elevated prolactin levels, a known side effect of medications like risperidone and paliperidone, can lead to symptoms such as missed periods, infertility, and unwanted lactation. This condition, called hyperprolactinemia, is often reversible once the medication is adjusted or discontinued—but without proactive monitoring, it can go unnoticed for months.
Pregnancy planning and birth defect risk are essential discussions for anyone considering a future pregnancy. Valproate, while effective, is associated with increased risk of serious birth defects and developmental delays if used during pregnancy. Other options, like lamotrigine, may offer a safer profile but still require thoughtful planning and close coordination with both psychiatric and obstetric care teams.
Emerging Options With Fewer Side Effects
The good news is that newer medications offer effective treatment with fewer metabolic or reproductive side effects. For example, lumateperone (Caplyta) has been shown to carry a lower risk of weight gain and metabolic disruption. Cariprazine (Vraylar) is another newer option with a more favorable side effect profile, often helpful in both manic and depressive episodes. Lybalvi, a combination of olanzapine with samidorphan, is designed to reduce the weight gain typically associated with olanzapine alone.
While no medication is side-effect free, there are more options than ever that allow for better tailoring to each woman’s needs.
What to Discuss With Your Provider
When starting or adjusting treatment, it’s important to bring up questions that address the whole picture—not just symptom reduction. Women should feel empowered to ask about the risks of hair loss, weight changes, fertility disruptions, and how each medication aligns with current or future plans for pregnancy.
It’s also helpful to ask whether hormone levels such as prolactin will be monitored, especially if irregular periods or signs of hormonal imbalance arise during treatment. You can also discuss whether there’s a plan in place to track metabolic health over time, including weight, cholesterol, blood sugar, and blood pressure.
You Deserve a Different Kind of Care
At Different Mental Health, we believe psychiatric care should be collaborative, individualized, and designed around your goals. Whether you’re managing bipolar disorder, planning a pregnancy, or simply tired of being told to “just live with” side effects that affect your body and identity—we’re here to help.
Our team includes experts who teach other providers across the country, and we’re proud to offer thoughtful, research-based care that’s always focused on what matters most to you.
Frequently Asked Questions: Bipolar Disorder in Women
Yes. Hormonal factors, pregnancy, menstrual cycles, and life stressors can influence how symptoms appear and fluctuate in women.
Hormonal shifts during puberty, pregnancy, postpartum, and menopause can impact mood stability and may trigger bipolar symptoms.
Some medications require careful planning with your clinician due to potential risks; preconception counseling is important for medication decisions.
Women may present with overlapping anxiety and depression symptoms, leading to diagnostic delay or misclassification unless a thorough bipolar evaluation is done.
Regular sleep, consistent routines, stress management, and mindfulness practices are helpful alongside clinical treatment.
It helps to prepare a symptom journal, discuss hormonal patterns, and clarify treatment goals before appointments.
Some medications may interact with hormonal regulation; discussing family planning goals with your clinician is recommended.
Therapies like CBT, IPSRT, and DBT are effective for all genders, but tailoring to life context and stressors may improve relevance.
References
Ismayilova, S., & Şahin, Y. (2023). Association of Valproic Acid With Polycystic Ovary Syndrome: A Meta-Analysis. Frontiers in Psychiatry.
Williams, E., & Azzopardi, D. (2020). Hyperprolactinaemia and Antipsychotics. BMJ Open Quality, 9(1).
Durgam, S., Starace, A., Li, D., et al. (2021). Weight Mitigation With Samidorphan–Olanzapine Combination. Journal of Clinical Psychiatry, 82(3).
Correll, C. U., et al. (2020). Cardiometabolic Risk With Antipsychotics. World Psychiatry, 19(1), 71–89.
